ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The cancer risk with "light" drinking"
Episode Synopsis
There has been back-and-forth on the health risks of light or moderate alcohol consumption. Recent reviews have tried to narrow down the cancer risks associated with drinking. Also, the heart benefits of GLP-1s like Ozempic and Wegovy could be dependent on your BMI, based on a new study in people with type 2 diabetes. And an update from the Australian Health Practitioner Regulation Agency (AHPRA) on GLP-1 prescribing practices. ReferencesAlcohol and Cancer Risk - JAMA InsightsReview of Evidence on Alcohol and Health - National Academies of Sciences, Engineering, and MedicineGLP-1 RAs and Cardiovascular and Kidney Outcomes by Body Mass Index in Type 2 Diabetes Incidence of GLP‐1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011–2022: a retrospective open cohort studyJoint statement on professional responsibilities for prescribing and dispensing medicines - AHPRA
More episodes of the podcast Health Report - Separate stories podcast
Should we be funding more medical research?
04/10/2025
Mailbag: Learning how to fall
04/10/2025
Mailbag: Lp(a) and aspirin
27/09/2025
In God we trust